Recombinant staphylokinase (Shijiazhuang Yiling Pharmaceutical)
重组葡激酶（石家庄以岭药业）
Report date: 2022/07/15 15:58:55
Base Information
Drug NameRecombinant staphylokinase (Shijiazhuang Yiling Pharmaceutical)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesShijiazhuang Yiling Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesN/A
Inactive CompaniesShijiazhuang Yiling Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A